Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Grace Life-tech Holdings Limited ( (HK:2112) ) has shared an announcement.
Grace Life-tech Holdings Limited announced its continued growth in the plant stem cell sector by acquiring five new customers in the first half of 2025. The company is in the process of restructuring its debt and is negotiating with a potential strategic partner in China to establish a headquarters and integrated hub for its plant stem cell business. Additionally, the company has successfully reduced administrative costs by approximately 20% in the second quarter of 2025 compared to the previous year.
More about Grace Life-tech Holdings Limited
Grace Life-tech Holdings Limited operates in the plant stem cell industry, focusing on expanding its business presence in China. The company is engaged in developing a plant stem cell business and aims to enhance distributor engagement through strategic partnerships.
Average Trading Volume: 2,750,250
Technical Sentiment Signal: Sell
Current Market Cap: HK$94.5M
Find detailed analytics on 2112 stock on TipRanks’ Stock Analysis page.